EPO Patents = 1

Trademarks = 1

Forward Citations = 82

Loading Chart...

6 inventors (with patents filed for the assignee):

Jingrong Jean Cui (4 out of 45 patents)

Evan W Rogers (4 out of 47 patents)

Dayong Zhai (3 out of 22 patents)

4. Yishan Li (3 out of 10 patents)

5. Jane Ung (1 out of 19 patents)

6. Wei Deng (1 out of 14 patents)

4 patents: Sort by Forward Citations

1. 10316044 - Chiral diaryl macrocycles as modulators of protein kinases (2019-06-11),

2. 10294242 - Diaryl macrocycle polymorph (2019-05-21),

3. 10246466 - Diaryl macrocycles as modulators of protein kinases (2019-04-02),

4. 9714258 - Diaryl macrocycles as modulators of protein kinases (2017-07-25),

TP Therapeutics is a precision oncology company dedicated to identifying and rapidly advancing novel targets and therapies to address unmet medical needs in cancer. Their lead candidate, TPX-0022, is a potent and selective inhibitor of MET/CSF1R/ALK. The company is committed to improving outcomes for cancer patients through innovative targeted therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

4 Patents

#1,005 in San Diego, CA

#14,030 in California

#60,532 in US

San Diego, CA, United States of America

Tp Therapeutics, Inc.